The objective of this study is the role of vaginal progesterone gel in the treatment of menopausal hypoactive sexual desire disorder. Half of the study participants will receive a standard dose of self applied vaginal progesterone gel and the other half will receive oral vitamin tablets.
Steroid hormones play fundamental roles in sexual behaviour. Sexual activity is related to hormone concentrations and ovulation in women. Women's sexuality, unlike that of most mammals, is not solely defined by sexual receptivity during the short window of fertility. Women are also prone to initiate luteal-phase sex when serum levels of progesterone are highest in the menstrual cycle.As a result of ovarian hormonal cessation after menopause women may face alterations in sexual desire. The role of progesterone supplementation in improving sexual desire in the menopausal period is investigated.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
30
vaginal self application
Bezmialem Vakif University
Istanbul, Turkey (Türkiye)
RECRUITINGFSFI (Female Sexual Function Index) questionnaire "arousal" domain
Increment
Time frame: 1 month
FSFI (Female Sexual Function Index) questionnaire "lubrication" domain
Increment
Time frame: 1 month
FSFI (Female Sexual Function Index) questionnaire all domains
Increment
Time frame: 1 month
FSDS-R (Female Sexual Distress Scale- Revised) score
Decline
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.